----

----

----

----

----

----

|                                                     |   | 2015   |        |   | 2014   |   |       | 2013   |   |
|----------------------------------------------------------|--------|--------|-------------|--------|--------|--------|------------|--------|--------|
|                                                     |   |        |        |   |        |   |       |        |   |
| Anesthesia services revenue                              |   | $      | 36,496,035  |   |   | $      | 3,386,073  |   |   | $ | - |   |
| Product sales revenue                                    |   |   | 9,552,445   |   |   |   | 8,598,097  |   |   |   | 7,682,628 |   |
| Total revenue                                            |   |   | 46,048,480  |   |   |   | 11,984,170 |   |   |   | 7,682,628 |   |
|                                                     |   |   |        |   |   |   |       |   |   |   |   |   |
| Operating expenses – adjusted1                     |   |   |        |   |   |   |       |   |   |   |   |   |
| Anesthesia services                                      |   |   | 15,528,409  |   |   |   | 1,255,193  |   |   |   | - |   |
| Product sales                                            |   |   | 3,723,633   |   |   |   | 3,868,830  |   |   |   | 4,012,358 |   |
| Corporate                                                |   |   | 2,764,803   |   |   |   | 2,164,053  |   |   |   | 1,53,707 |   |
| Total operating expenses – adjusted1               |   |   | 22,016,845  |   |   |   | 7,288,076  |   |   |   | 5,566,065 |   |
|                                                     |   |   |        |   |   |   |       |   |   |   |   |   |
| Operating EBITDA2 – non-controlling interest3      |   |   | 607,289     |   |   |   | -          |   |   |   | - |   |
| Operating EBITDA2 - shareholders of the Company          |   |   | 23,424,346  |   |   |   | 4,696,094  |   |   |   | 2,116,563 |   |
| Operating EBITDA2 - total                                |   |   | 24,031,635  |   |   |   | 4,696,094  |   |   |   | 2,116,563 |   |
|                                                     |   |   |        |   |   |   |       |   |   |   |   |   |
| Operating income                                         |   |   | 13,431,186  |   |   |   | 2,977,893  |   |   |   | 1,799,795 |   |
| Net and comprehensive income                             |   | $      | 3,259,828   |   |   | $      | 1,498,153  |   |   | $ | 2,492,646 |   |
| Attributable to:                                         |   |   |        |   |   |   |       |   |   |   |   |   |
| Shareholders of the Company                              |   |   | 3,076,191   |   |   |   | 1,498,153  |   |   |   | 2,492,646 |   |
| Non-controlling interest(3)                              |   |   | 183,637     |   |   |   | -          |   |   |   | - |   |
|                                                     |   |   |        |   |   |   |       |   |   |   |   |   |
| Operating EBITDA per share attributable to shareholders: |   |   |        |   |   |   |       |   |   |   |   |   |
| Basic                                                    |   | $      | 0.345       |   |   | $      | 0.096      |   |   | $ | 0.043 |   |
| Diluted                                                  |   | $      | 0.331       |   |   | $      | 0.094      |   |   | $ | 0.043 |   |
|                                                     |   |   |        |   |   |   |       |   |   |   |   |   |
| Earnings per share attributable to shareholders:         |   |   |        |   |   |   |       |   |   |   |   |   |
| Basic                                                    |   | $      | 0.045       |   |   | $      | 0.031      |   |   | $ | 0.051 |   |
| Diluted                                                  |   | $      | 0.043       |   |   | $      | 0.030      |   |   | $ | 0.051 |   |
|                                                     |   |   |        |   |   |   |       |   |   |   |   |   |
| Total assets                                             |   | $      | 104,495,278 |   |   | $      | 78,964,290 |   |   | $ | 8,633,372 |   |
| Total non-current liabilities                            |   | $      | 39,389,376  |   |   | $      | 46,950,391 |   |   | $ | - |   |
| Total liabilities                                        |   | $      | 47,520,913  |   |   | $      | 60,176,928 |   |   | $ | 353,253 |   |

----

----

| Payor                | Year ended December 31, 2015 |
|----------------------|------------------------------|
| Medicare             | 27.2%                        |
| Medicaid             | 4.1%                         |
| Commercial and other | 68.7%                        |
| Total                | 100.0%                       |

----

----

----

----

----

----

----

| (in 000's of US$, except EPS)                           |   | Q4 '15 |   |   | Q3 '15 |   |   | Q2 '15 |   |   | Q1 '15 |   |   | Q4 '14 |   |   | Q3 '14 |   |   | Q2 '14  |   |   | Q1 '14 |   |
|---------------------------------------------------------|--------|--------|--------|--------|--------|--------|--------|--------|--------|--------|--------|--------|--------|--------|--------|--------|--------|--------|--------|---------|--------|--------|--------|--------|
| Anesthesia services revenue1                            |   |   | 11,330 |   |   |   | 9,195  |   |   |   | 8,514  |   |   |   | 7,457  |   |   |   | 3,386  | 3  |   |   | -      |   |   |   | - |   |   |   | - |   |
| Product sales revenue                                   |   |   | 2,608  |   |   |   | 2,415  |   |   |   | 2,367  |   |   |   | 2,163  |   |   |   | 2,360  |    |   |   | 2,200  |   |   |   | 2,046 |   |   |   | 1,991 |   |
| Total revenue                                           |   |   | 13,938 |   |   |   | 11,610 |   |   |   | 10,881 |   |   |   | 9,620  |   |   |   | 5,746  |    |   |   | 2,200  |   |   |   | 2,046 |   |   |   | 1,991 |   |
| Operating expenses – adjusted2                    |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |    |   |   |   |   |   |   |   |   |   |   |   |   |
| Anesthesia services2                                    |   |   | 5,061  |   |   |   | 4,023  |   |   |   | 3,460  |   |   |   | 2,984  |   |   |   | 1,255  |    |   |   | -      |   |   |   | - |   |   |   | - |   |
| Product sales2                                          |   |   | 950    |   |   |   | 888    |   |   |   | 981    |   |   |   | 904    |   |   |   | 978    |    |   |   | 1,034  |   |   |   | 990 |   |   |   | 867 |   |
| Corporate2                                              |   |   | 664    |   |   |   | 798    |   |   |   | 665    |   |   |   | 639    |   |   |   | 843    |    |   |   | 445    |   |   |   | 442 |   |   |   | 434 |   |
| Total operating expenses – adjusted1              |   |   | 6,675  |   |   |   | 5,709  |   |   |   | 5,106  |   |   |   | 4,527  |   |   |   | 3,076  |    |   |   | 1,479  |   |   |   | 1,432 |   |   |   | 1,301 |   |
| Operating EBITDA3 - non-controlling interest4           |   |   | 465    |   |   |   | 142    |   |   |   | -      |   |   |   | -      |   |   |   | -      |    |   |   | -      |   |   |   | - |   |   |   | - |   |
| Operating EBITDA3 - shareholders of the Company         |   |   | 6,797  |   |   |   | 5,759  |   |   |   | 5,775  |   |   |   | 5,093  |   |   |   | 2,670  |    |   |   | 721    |   |   |   | 614 |   |   |   | 691 |   |
| Operating EBITDA3 - total                               |   |   | 7,264  |   |   |   | 5,901  |   |   |   | 5,775  |   |   |   | 5,093  |   |   |   | 2,670  |    |   |   | 721    |   |   |   | 614 |   |   |   | 691 |   |
| Operating income                                        |   |   | 4,673  |   |   |   | 2,285  |   |   |   | 3,154  |   |   |   | 3,320  |   |   |   | 1,285  |    |   |   | 630    |   |   |   | 501 |   |   |   | 562 |   |
| Net finance expense                                     |   |   | 5,914  |   |   |   | 1,013  |   |   |   | 4,492  |   |   |   | 1,665  |   |   |   | 1,623  |    |   |   | -      |   |   |   | - |   |   |   | - |   |
| Income tax expense (recovery)                           |   |   | (1,541 | )      |   |   | (442   | )      |   |   | (661   | )      |   |   | (269   | )      |   |   | (721   | )       |   |   | 210    |   |   |   | 174 |   |   |   | 194 |   |
| Net income (loss)                                       |   |   | 299    |   |   |   | 1,714  |   |   |   | (678   | )      |   |   | 1,924  |   |   |   | 383    |    |   |   | 420    |   |   |   | 327 |   |   |   | 368 |   |
| Attributable to:                                        |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |    |   |   |   |   |   |   |   |   |   |   |   |   |
| Shareholders of the Company                             |   |   | 154    |   |   |   | 1,676  |   |   |   | (678   | )      |   |   | 1,924  |   |   |   | 383    |    |   |   | 420    |   |   |   | 327 |   |   |   | 368 |   |
| Non-controlling interest(4)                             |   |   | 145    |   |   |   | 38     |   |   |   | -      |   |   |   | -      |   |   |   | -      |    |   |   | -      |   |   |   | - |   |   |   | - |   |
|                                                    |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |    |   |   |   |   |   |   |   |   |   |   |   |   |
| Operating EBITDA per share attributable to shareholders |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |    |   |   |   |   |   |   |   |   |   |   |   |   |
| Basic                                                   |   |   | 0.096  |   |   |   | 0.083  |   |   |   | 0.083  |   |   |   | 0.083  |   |   |   | 0.056  |    |   |   | 0.015  |   |   |   | 0.013 |   |   |   | 0.014 |   |
| Diluted                                                 |   |   | 0.092  |   |   |   | 0.080  |   |   |   | 0.083  |   |   |   | 0.080  |   |   |   | 0.049  |    |   |   | 0.015  |   |   |   | 0.012 |   |   |   | 0.014 |   |
| Earnings per share attributable to shareholders         |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |    |   |   |   |   |   |   |   |   |   |   |   |   |
| Basic                                                   |   |   | 0.002  |   |   |   | 0.024  |   |   |   | (0.010 | )      |   |   | 0.031  |   |   |   | 0.008  |    |   |   | 0.009  |   |   |   | 0.007 |   |   |   | 0.008 |   |
| Diluted                                                 |   |   | 0.002  |   |   |   | 0.023  |   |   |   | (0.010 | )      |   |   | 0.030  |   |   |   | 0.007  |    |   |   | 0.009  |   |   |   | 0.007 |   |   |   | 0.007 |   |

----

----

| Financial Covenant          | Required Ratio |
|-----------------------------|----------------|
| Senior debt to EBITDA ratio | 2.25:1.00      |
| Total funded debt ratio     | 3.00:1.00      |
| Fixed charge coverage ratio | 1.30:1.00      |

----

|  At December 31, 2015     |   |        |       |   | Maturity           |   |
|--------------------------------|--------|--------|------------|--------|--------------------|--------|
|                           |   | TOTAL  |       |   | Less than one year |   |   | One to three years |   |   | Four to five years |   |   | After five years |   |
| Trade and other payables       |   | $      | 3,034,363  |   |               | $      | 3,034,363 |   |   | $ | - |   |   | $ | - |   |   | $ | - |   |
| Employee benefits              |   |   | 142,576    |   |               |   | 142,576 |   |   |   | - |   |   |   | - |   |   |   | - |   |
| Notes payable and indebtedness |   |   | 30,738,466 |   |               |   | 3,818,048 |   |   |   | 26,920,418 |   |   |   | - |   |   |   | - |   |
| Loans                          |   |   | 266,994    |   |               |   | 266,994 |   |   |   | - |   |   |   | - |   |   |   | - |   |
| Earn-out obligation            |   |   | 12,468,958 |   |               |   | - |   |   |   | 12,468,958 |   |   |   |   |   |   |   |   |   |
|                           |   | $      | 46,651,357 |   |               | $      | 7,261,981 |   |   | $ | 39,389,376 |   |   | $ | - |   |   | $ | - |   |

----

|  | (a) | Related party transactions: |
|--|-----|-----------------------------|

|  | (b) | Compensation of key management personnel: |
|--|-----|-------------------------------------------|

|                                         |   | 2015   |      |   | 2014   |   |
|----------------------------------------------|--------|--------|-----------|--------|--------|--------|
|                                         |   |        |      |   |        |   |
| Salaries, directors' fees and other benefits |   | $      | 988,647   |   |   | $      | 1,221,387 |   |
| Share-based payments                         |   |   | 2,295,237 |   |   |   | 289,293 |   |
|                                         |   |   |      |   |   |   |   |   |
|                                         |   | $      | 3,283,884 |   |   | $      | 1,510,680 |   |

|  | (i) | Share-based payments represent the amount expensed during the year for options granted. |
|--|-----|-----------------------------------------------------------------------------------------|

|  | (ii) | There were no post-employment, termination or other long-term benefits paid during the years ending December 31, 2015 and 2014. |
|--|------|---------------------------------------------------------------------------------------------------------------------------------|

----

----

| (b) | Revenue recognition – Anesthesia services: |
|-----|--------------------------------------------------|

----

| (c) | Accounts receivable and allowance for doubtful accounts: |
|-----|----------------------------------------------------------|

----

|  | · | Changes in method for disposal under IFRS 5 Non-current Assets Held for Sale and Discontinued Operations; |
|--|--------|-----------------------------------------------------------------------------------------------------------|

|  | · | 'Continuing involvement' for servicing contracts and offsetting disclosures in condensed interim financial statements under IFRS 7 Financial Instruments: Disclosures; |
|--|--------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | · | Discount rate in a regional market sharing the same currency under IAS 19 Employee Benefits; |
|--|--------|----------------------------------------------------------------------------------------------|

|  | · | Disclosure of information 'elsewhere in the interim financial report' under IAS 34 Interim Financial Reporting; |
|--|--------|-----------------------------------------------------------------------------------------------------------------|

----

----

|                      |   | 2015   |       |   | 2014   |   |
|---------------------------|--------|--------|------------|--------|--------|--------|
|                      |   |        |       |   |        |   |
| Cash and cash equivalents |   | $      | 3,572,344  |   |   | $      | 4,133,663 |   |
| Trade receivables         |   |   | 7,031,030  |   |   |   | 3,334,462 |   |
|                      |   |   |       |   |   |   |   |   |
|                      |   | $      | 10,603,374 |   |   | $      | 7,468,125 |   |

----

----

|  | (i) | Foreign currency risk: |
|--|-----|------------------------|

| Expressed in U.S. dollar equivalent                      |   | 2015   |       |   | 2014   |   |
|----------------------------------------------------------|--------|--------|------------|--------|--------|--------|
|                                                     |   |        |       |   |        |   |
| Cash and cash equivalents                                |   | $      | 71,378     |   |   | $      | 67,521 |   |
| Trade and other receivables                              |   |   | 66,094     |   |   |   | 32,452 |   |
| Trade and other payables and other financial liabilities |   |   | 501,888    |   |   |   | 771,893 |   |
| Notes payable                                            |   |   | 14,179,589 |   |   |   | 16,418,166 |   |
|                                                     |   |   |       |   |   |   |   |   |

----

----

----

| For the three months ended        |   | 2015   |   |   | 2014   |   |   | For the year ended |   |
|-----------------------------------|--------|--------|--------|--------|--------|--------|--------|--------------------|--------|
| (USD in thousands)                |   | Dec    |   |   | Sep    |   |   | Jun                |   |   | Mar |   |   | Dec |   |   | Sep |   |   | Jun |   |   | Mar |   |   | 2015 |   |   | 2014 |   |   | 2013 |   |
| Operating EBITDA attributable to: |   |        |   |   |        |   |   |                    |   |   |  |   |   |  |   |   |  |   |   |  |   |   |  |   |   |  |   |   |  |   |   |  |   |
| Shareholders of the Company       |   |   | 6,797  |   |   |   | 5,758  |               |   |   | 5,775 |   |   |   | 5,093 |   |   |   | 2,670 |   |   |   | 721 |   |   |   | 614 |   |   |   | 691 |   |   |   | 23,425 |   |   |   | 4,696 |   |   |   | 2,117 |   |
| Non-controlling interest          |   |   | 465    |   |   |   | 142    |               |   |   | - |   |   |   | - |   |   |   | - |   |   |   | - |   |   |   | - |   |   |   | - |   |   |   | 607 |   |   |   | - |   |   |   | - |   |
| Total Operating EBITDA            |   |   | 7,263  |   |   |   | 5,900  |               |   |   | 5,775 |   |   |   | 5,093 |   |   |   | 2,670 |   |   |   | 721 |   |   |   | 614 |   |   |   | 691 |   |   |   | 24,032 |   |   |   | 4,696 |   |   |   | 2,117 |   |
| Amortization expense              |   |   | (2,188 | )      |   |   | (1,745 | )                  |   |   | (1,459 | ) |   |   | (1,402 | ) |   |   | (458 | ) |   |   | - |   |   |   | - |   |   |   | - |   |   |   | (6,795 | ) |   |   | (458 | ) |   |   | - |   |
| Depreciation and related expense  |   |   | (18    | )      |   |   | (17    | )                  |   |   | (17 | ) |   |   | (12 | ) |   |   | (13 | ) |   |   | (10 | ) |   |   | (12 | ) |   |   | (18 | ) |   |   | (64 | ) |   |   | (53 | ) |   |   | (83 | ) |
| Stock based compensation          |   |   | (261   | )      |   |   | (1,001 | )                  |   |   | (1,145 | ) |   |   | (343 | ) |   |   | (69 | ) |   |   | (82 | ) |   |   | (101 | ) |   |   | (110 | ) |   |   | (2,749 | ) |   |   | (362 | ) |   |   | (235 | ) |
| Acquisition expenses              |   |   | (123   | )      |   |   | (221   | )                  |   |   | - |   |   |   | (16 | ) |   |   | (845 | ) |   |   | - |   |   |   | - |   |   |   | - |   |   |   | (361 | ) |   |   | (845 | ) |   |   | - |   |
| Impairment of inventory           |   |   | -      |   |   |   | (241   | )                  |   |   | - |   |   |   | - |   |   |   | - |   |   |   | - |   |   |   | - |   |   |   | - |   |   |   | (241 | ) |   |   | - |   |   |   | - |   |
| Impairment of intangible assets   |   |   | -      |   |   |   | (390   | )                  |   |   | - |   |   |   | - |   |   |   | - |   |   |   | - |   |   |   | - |   |   |   | - |   |   |   | (390 | ) |   |   | - |   |   |   | - |   |
| Operating income                  |   |   | 4,673  |   |   |   | 2,285  |               |   |   | 3,154 |   |   |   | 3,320 |   |   |   | 1,285 |   |   |   | 629 |   |   |   | 501 |   |   |   | 563 |   |   |   | 13,431 |   |   |   | 2,978 |   |   |   | 1,799 |   |
| For the three months ended                             |   | 2015   |   |   | 2014   |   |   | For the year ended |   |
|--------------------------------------------------------|--------|--------|--------|--------|--------|--------|--------|--------------------|--------|
|  (USD in thousands)                               |   | Dec    |   |   | Sep    |   |   | Jun                |   |   | Mar |   |   | Dec |   |   | Sep |   |   | Jun |   |   | Mar |   |   | 2015 |   |   | 2014 |   |   | 2013 |   |
|                                                   |   |        |   |   |        |   |   |                    |   |   |  |   |   |  |   |   |  |   |   |  |   |   |  |   |   |  |   |   |  |   |   |  |   |
| Anesthesia services operating expense – adjusted |   |   | 5,061  |   |   |   | 4,023  |               |   |   | 3,460 |   |   |   | 2,984 |   |   |   | 1,255 |   |   |   | - |   |   |   | - |   |   |   | - |   |   |   | 15,528 |   |   |   | 1,255 |   |   |   | - |   |
| Amortization expense                                   |   |   | 2,188  |   |   |   | 1,745  |               |   |   | 1,459 |   |   |   | 1,403 |   |   |   | 458 |   |   |   | - |   |   |   | - |   |   |   | - |   |   |   | 6,795 |   |   |   | 458 |   |   |   | - |   |
| Depreciation and related expense                       |   |   | 4      |   |   |   | 3      |               |   |   | 2 |   |   |   | - |   |   |   | - |   |   |   | - |   |   |   | - |   |   |   | - |   |   |   | 8 |   |   |   | - |   |   |   | - |   |
| Stock based compensation                               |   |   | 12     |   |   |   | 13     |               |   |   | 10 |   |   |   | 2 |   |   |   | - |   |   |   | - |   |   |   | - |   |   |   | - |   |   |   | 37 |   |   |   | - |   |   |   | - |   |
| Acquisition expenses                                   |   |   | 123    |   |   |   | 221    |               |   |   | - |   |   |   | - |   |   |   | - |   |   |   | - |   |   |   | - |   |   |   | - |   |   |   | 345 |   |   |   | - |   |   |   | - |   |
| Impairment of intangible assets                        |   |   | -      |   |   |   | 390    |               |   |   | - |   |   |   | - |   |   |   | - |   |   |   | - |   |   |   | - |   |   |   | - |   |   |   | 390 |   |   |   | - |   |   |   | - |   |
| Anesthesia services expense                            |   |   | 7,389  |   |   |   | 6,395  |               |   |   | 4,931 |   |   |   | 4,389 |   |   |   | 1,713 |   |   |   | - |   |   |   | - |   |   |   | - |   |   |   | 23,103 |   |   |   | 1,713 |   |   |   | - |   |
|                                                   |   |   |   |   |   |   |   |               |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
| Product sales operating expense – adjusted       |   |   | 950    |   |   |   | 888    |               |   |   | 981 |   |   |   | 904 |   |   |   | 978 |   |   |   | 1,034 |   |   |   | 990 |   |   |   | 867 |   |   |   | 3,724 |   |   |   | 3,869 |   |   |   | 4,012 |   |
| Amortization expense                                   |   |   | -      |   |   |   | -      |               |   |   | - |   |   |   | - |   |   |   | - |   |   |   | - |   |   |   | - |   |   |   | - |   |   |   | - |   |   |   | - |   |   |   | - |   |
| Depreciation and related expense                       |   |   | 1      |   |   |   | 1      |               |   |   | 1 |   |   |   | 1 |   |   |   | 1 |   |   |   | - |   |   |   | 1 |   |   |   | 7 |   |   |   | 3 |   |   |   | 9 |   |   |   | 26 |   |
| Stock based compensation                               |   |   | 81     |   |   |   | 106    |               |   |   | 80 |   |   |   | 136 |   |   |   | 22 |   |   |   | 19 |   |   |   | 21 |   |   |   | 31 |   |   |   | 402 |   |   |   | 93 |   |   |   | 128 |   |
| Impairment of inventory                                |   |   | -      |   |   |   | 241    |               |   |   | - |   |   |   | - |   |   |   | - |   |   |   | - |   |   |   | - |   |   |   | - |   |   |   | 241 |   |   |   | - |   |   |   | - |   |
| Product sales expense                                  |   |   | 1,031  |   |   |   | 1,236  |               |   |   | 1,062 |   |   |   | 1,041 |   |   |   | 1,001 |   |   |   | 1,053 |   |   |   | 1,012 |   |   |   | 905 |   |   |   | 4,369 |   |   |   | 3,971 |   |   |   | 4,166 |   |
|                                                   |   |   |   |   |   |   |   |               |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
| Corporate operating expenses – adjusted          |   |   | 664    |   |   |   | 798    |               |   |   | 665 |   |   |   | 638 |   |   |   | 843 |   |   |   | 445 |   |   |   | 442 |   |   |   | 434 |   |   |   | 2,765 |   |   |   | 2,164 |   |   |   | 1,554 |   |
| Amortization expense                                   |   |   | -      |   |   |   | -      |               |   |   | - |   |   |   | - |   |   |   | - |   |   |   | - |   |   |   | - |   |   |   | - |   |   |   | - |   |   |   | - |   |   |   | - |   |
| Depreciation and related expense                       |   |   | 14     |   |   |   | 14     |               |   |   | 14 |   |   |   | 11 |   |   |   | 12 |   |   |   | 10 |   |   |   | 11 |   |   |   | 11 |   |   |   | 54 |   |   |   | 44 |   |   |   | 55 |   |
| Stock based compensation                               |   |   | 167    |   |   |   | 882    |               |   |   | 1,056 |   |   |   | 205 |   |   |   | 47 |   |   |   | 63 |   |   |   | 80 |   |   |   | 79 |   |   |   | 2,310 |   |   |   | 269 |   |   |   | 107 |   |
| Acquisition expenses                                   |   |   | -      |   |   |   | -      |               |   |   | - |   |   |   | 16 |   |   |   | 845 |   |   |   | - |   |   |   | - |   |   |   | - |   |   |   | 16 |   |   |   | 845 |   |   |   | - |   |
| Corporate expense                                      |   |   | 845    |   |   |   | 1,694  |               |   |   | 1,735 |   |   |   | 870 |   |   |   | 1,747 |   |   |   | 518 |   |   |   | 533 |   |   |   | 524 |   |   |   | 5,145 |   |   |   | 3,322 |   |   |   | 1,716 |   |
|                                                   |   |   |   |   |   |   |   |               |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
| Total operating expense – adjusted               |   |   | 6,675  |   |   |   | 5,709  |               |   |   | 5,106 |   |   |   | 4,527 |   |   |   | 3,076 |   |   |   | 1,479 |   |   |   | 1,432 |   |   |   | 1,301 |   |   |   | 22,017 |   |   |   | 7,288 |   |   |   | 5,566 |   |
| Total operating expense                                |   |   | 9,265  |   |   |   | 9,325  |               |   |   | 7,728 |   |   |   | 6,300 |   |   |   | 4,461 |   |   |   | 1,571 |   |   |   | 1,545 |   |   |   | 1,429 |   |   |   | 32,617 |   |   |   | 9,006 |   |   |   | 5,882 |   |

----